InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| ODN 2395 control | Regional infusion of a class C TLR9 agonist enhances liver tumor microenviron... | 2022 | Cancer Gene Ther. | Ghosh C.C. et al. | DOI: 10.1038/s41417-022-00484-z |
| ODN 2395 - TLR9 ligand | Regional infusion of a class C TLR9 agonist enhances liver tumor microenviron... | 2022 | Cancer Gene Ther. | Ghosh C.C. et al. | DOI: 10.1038/s41417-022-00484-z |
| Mouse TLR9 Reporter HEK293 Cells (NF-κB) | Regional infusion of a class C TLR9 agonist enhances liver tumor microenviron... | 2022 | Cancer Gene Ther. | Ghosh C.C. et al. | DOI: 10.1038/s41417-022-00484-z |
| Alpha Variant (B.1.1.7) Spike Expression Vectors | Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immun... | 2022 | Nat Microbiol | Vikkurthi R. et al. | DOI: 10.1038/s41564-022-01161-5 |
| Beta Variant (B.1.351) Spike Expression Vectors | Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immun... | 2022 | Nat Microbiol | Vikkurthi R. et al. | DOI: 10.1038/s41564-022-01161-5 |
| 2'3'-cGAMP VacciGrade™ | Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse mod... | 2022 | J Neuroinflammation | Ding R. et al. | DOI: 10.1186/s12974-022-02511-0 |
| RU.521 | Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse mod... | 2022 | J Neuroinflammation | Ding R. et al. | DOI: 10.1186/s12974-022-02511-0 |
| Pam3CSK4 | IL-1b expression in bone marrow dendritic cells is induced by TLR2 agonists a... | 2022 | Blood | Li S. et al. | DOI: 10.1182/blood.2022016084 |
| PGN-SA peptidoglycan preparation | IL-1b expression in bone marrow dendritic cells is induced by TLR2 agonists a... | 2022 | Blood | Li S. et al. | DOI: 10.1182/blood.2022016084 |
| LTA-SA | Staphylococcus aureus enhances gelatinase activities in monocytic U937 cells ... | 2022 | J Dent Sci. | Chang Y.H. et al. | DOI: 10.1016/j.jds.2022.04.014 |
| PGN-SA peptidoglycan preparation | Staphylococcus aureus enhances gelatinase activities in monocytic U937 cells ... | 2022 | J Dent Sci. | Chang Y.H. et al. | DOI: 10.1016/j.jds.2022.04.014 |
| Ionomycin | Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immun... | 2022 | Nat Commun. | Rappaport A.R. et al. | DOI: 10.1038/s41467-022-31005-z |
| PMA - Phorbol myristate acetate | Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immun... | 2022 | Nat Commun. | Rappaport A.R. et al. | DOI: 10.1038/s41467-022-31005-z |
| Plasmocin® - Mycoplasma Elimination Reagent | Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective B... | 2022 | Biomed Pharmacother. | Tsujikawa L.M. et al. | DOI: 10.1016/j.biopha.2022.113230 |
| QUANTI-Blue™ | Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies ... | 2022 | Vaccines (Basel) | Noailly B. et al. | DOI: 10.3390/vaccines10060903 |
| G418 (Geneticin) | Defining pervasive transcription units using chromatin RNA-sequencing data. | 2022 | STAR Protoc. | Guo Z. et al. | DOI: 10.1016/j.xpro.2022.101442 |
| LPS-EB (LPS from E. coli O111:B4) | Exploring the zinc-related transcriptional landscape in Alzheimer’s disease. | 2022 | IBRO Neurosci Rep. | Shippy D.C. & Ulland T.K. | DOI: 10.1016/j.ibneur.2022.06.002 |
| Torin 1 | Yersinia pestis-Induced Mitophagy That Balances Mitochondrial Homeostasis and... | 2022 | Microbiol Spectr. | Jiao Y. et al. | DOI: 10.1128/spectrum.00718-22 |
| Puromycin | C/EBPδ-induced epigenetic changes control the dynamic gene transcription of S... | 2022 | Elife | Jauch-Speer S.L. et al. | DOI: 10.7554/eLife.75594 |
| LPS-EB VacciGrade™ | Evaluation of a Lipopolysaccharide and Resiquimod Combination as an Adjuvant ... | 2022 | Vaccines (Basel). | Sharma B.K. et al. | DOI: 10.3390/vaccines10060894 |